Molbio Diagnostics IPO Subscription
ListedUpdated 17 August 2026, 9:15 AM IST· Mainboard
Molbio Diagnostics IPO subscription closed on 12 August 2026 at 70.26x overall by shares. QIB demand came in at 186.39x, NII at 49.80x, and retail at 12.96x. See Retail, SHNI, and BHNI allotment chances in the table…
Molbio Diagnostics IPO subscription closed on 12 August 2026 at 70.26x overall by shares. QIB demand came in at 186.39x, NII at 49.80x, and retail at 12.96x. See Retail, SHNI, and BHNI allotment chances in the table below.
Show moreShow less
Allotment date is 13 August 2026. Listing date on NSE and BSE is 17 August 2026.
Molbio Diagnostics IPO Day-wise Subscription
Daily QIB, NII, Retail, and overall subscription as bids come in
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 10 Aug 2026 | 1.00x | 0.73x | 0.77x | 0.83x |
| Day 2 - 11 Aug 2026 | 1.39x | 4.46x | 3.19x | 2.95x |
| Day 3 - 12 Aug 2026 | 186.39x | 49.80x | 12.97x | 70.27x |
Molbio Diagnostics IPO Allotment Chances
Retail, SHNI, and BHNI chances based on application subscription
Molbio Diagnostics IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.
| Category | Subscription (Apps) | Allotment Chances |
|---|---|---|
| Retail | 11.17x | 1 in 11 |
| SHNI (Rs 2L to Rs 10L) | 46.20x | 1 in 46 |
| BHNI (above Rs 10L) | 10.07x | 1 in 10 |
Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.
Check the Molbio Diagnostics IPO Allotment Status page from 13 August 2026 for your result.
Molbio Diagnostics IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 807.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 187.64 Cr | Rs 34,973.94 Cr | 186.39x |
| FII | - | Rs 13,864.61 Cr | - |
| DFI | - | Rs 16,837.59 Cr | - |
| Mutual Funds | - | Rs 1,936.76 Cr | - |
| Other | - | Rs 2,334.97 Cr | - |
| NII | Rs 140.73 Cr | Rs 7,008.04 Cr | 49.80x |
| bNII (above Rs 10L) | Rs 93.82 Cr | Rs 4,767.48 Cr | 50.82x |
| Corporate | - | Rs 85.51 Cr | - |
| Individual | - | Rs 4,491.55 Cr | - |
| Other | - | Rs 190.42 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 46.91 Cr | Rs 2,240.56 Cr | 47.76x |
| Corporate | - | Rs 9.58 Cr | - |
| Individual | - | Rs 2,147.27 Cr | - |
| Other | - | Rs 83.71 Cr | - |
| Retail | Rs 328.37 Cr | Rs 4,254.45 Cr | 12.96x |
| Cut-off price | - | Rs 3,580.66 Cr | - |
| Fixed price | - | Rs 673.79 Cr | - |
| Employee | Rs 1.66 Cr | Rs 21.99 Cr | 13.28x |
| Cut-off price | - | Rs 16.59 Cr | - |
| Fixed price | - | Rs 5.40 Cr | - |
| Total | Rs 658.39 Cr | Rs 46,258.41 Cr | 70.26x |
Molbio Diagnostics IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 23,25,146 | 915 | 0.00x |
| FII | - | 87 | - |
| DFI | - | 55 | - |
| Mutual Funds | - | 387 | - |
| Other | - | 386 | - |
| NII | 6,920 | 1,53,031 | 22.11x |
| bNII (above Rs 10L) | 4,613 | 46,444 | 10.07x |
| Corporate | - | 794 | - |
| Individual | - | 43,808 | - |
| Other | - | 1,842 | - |
| sNII (Rs 2L to Rs 10L) | 2,307 | 1,06,587 | 46.20x |
| Corporate | - | 411 | - |
| Individual | - | 1,02,126 | - |
| Other | - | 4,050 | - |
| Retail | 2,26,056 | 25,24,964 | 11.17x |
| Cut-off price | - | 21,14,641 | - |
| Fixed price | - | 4,10,323 | - |
| Employee | 1,140 | 8,854 | 7.77x |
| Cut-off price | - | 6,883 | - |
| Fixed price | - | 1,971 | - |
| Total | 25,59,262 | 26,87,764 | 1.05x |
What Do These Subscription Numbers Mean?
70.26x overall by shares means bids covered about 70 times the shares on offer. Allotment chances depend on applications in each category.
QIB at 186.39x by shares shows institutional demand from mutual funds, FIIs, and banks.
NII covers bids above Rs 2 lakh (22.11x by applications). Split: SHNI 46.20x, BHNI 10.07x by applications. SHNI and BHNI allotment is by lottery.
At 11.17x subscription by applications, about 1 in 11 retail applicants may get allotment (~9% chance per application). Retail allotment is also by lottery.
Molbio Diagnostics IPO GMP After Subscription
GMP for Molbio Diagnostics IPO stands at Rs 120.00 today, giving an estimated listing price of Rs 927.00 per share.
A subscription of 70.26x combined with a GMP of 14.87% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Molbio Diagnostics IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Molbio Diagnostics IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 10 August 2026 |
| IPO Close Date | 12 August 2026 |
| Allotment Date | 13 August 2026 |
| Refund Initiation | 14 August 2026 |
| Share Credit to Demat | 14 August 2026 |
| Listing Date | 17 August 2026 |
| Minimum Investment | Rs 14,526.00 |
| Lot Size | 18 shares |
About Molbio Diagnostics IPO
Molbio Diagnostics Limited (incorporated in 2000 as Molbio Diagnostics Private Limited) is a point-of-care (POC) diagnostics company focused on delivering accurate, rapid, and cost-effective healthcare technologies for infectious and non-communicable diseases. The company developed the 'Truenat' platform, a portable polymerase chain reaction (PCR) system that enables decentralized molecular testing for 30 diseases across 42 assays, patented in over 100 countries. Its Truenat TB test is WHO-endorsed for initial TB diagnosis and rifampicin resistance detection.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors (SHNI & BHNI)
Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.
Retail - Retail Individual Investors
Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.
Molbio Diagnostics IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Molbio Diagnostics IPO Details
Issue size, price, financials, and company info
Molbio Diagnostics IPO GMP
Live grey market premium and listing estimate
Molbio Diagnostics IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Molbio Diagnostics IPO Allotment
Allotment date, chances, and check by PAN
Molbio Diagnostics IPO Review
SWOT, strengths, risks, and IPO review
Molbio Diagnostics IPO FAQ
Common questions on dates, GMP, and allotment
Molbio Diagnostics IPO Registrar
Registrar website and how to check allotment
Molbio Diagnostics IPO Timeline
Open, close, allotment, and listing dates
Molbio Diagnostics IPO News
Updates, blogs, and latest IPO news
Molbio Diagnostics IPO Subscription FAQs
What is Molbio Diagnostics IPO subscription status today?
Molbio Diagnostics IPO subscription closed on 12 August 2026 with overall subscription of 70.26x (by shares) as of 19 August 2026, 4:32 AM IST. QIB 186.39x, NII 22.11x, Retail 11.17x.
What is the overall subscription of Molbio Diagnostics IPO?
Molbio Diagnostics IPO is subscribed 70.26x overall by shares at close on 12 August 2026. QIB 186.39x, NII 22.11x, and Retail 11.17x.
What is Molbio Diagnostics IPO QIB subscription?
Molbio Diagnostics IPO QIB (Qualified Institutional Buyers) subscription is 186.39x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Molbio Diagnostics IPO Retail subscription?
Molbio Diagnostics IPO Retail subscription is 11.17x by applications. Retail bids are up to Rs 2 lakh per PAN.
What is Molbio Diagnostics IPO NII, SHNI, and BHNI subscription?
Molbio Diagnostics IPO NII subscription is 22.11x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 46.20x and BHNI (above Rs 10L) at 10.07x.
What are Molbio Diagnostics IPO retail allotment chances?
At 11.17x subscription by applications, about 1 in 11 retail applicants may get allotment (~9% chance per application). Allotment is by lottery. Share subscription was 12.96x. Allotment chances use applications, not share volume.
What are Molbio Diagnostics IPO SHNI allotment chances?
At 46.20x subscription by applications, about 1 in 46 SHNI applicants may get allotment (~2% chance per application). Allotment is by lottery. Share subscription was 47.76x. Allotment chances use applications, not share volume.
What are Molbio Diagnostics IPO BHNI allotment chances?
At 10.07x subscription by applications, about 1 in 10 BHNI applicants may get allotment (~10% chance per application). Allotment is by lottery. Share subscription was 50.82x. Allotment chances use applications, not share volume.
When is Molbio Diagnostics IPO allotment date?
Molbio Diagnostics IPO allotment date is 13 August 2026. Check Molbio Diagnostics IPO Allotment Status on IPOwiz from that day using your PAN.
When does Molbio Diagnostics IPO subscription close?
Molbio Diagnostics IPO subscription closed on 12 August 2026. No new applications are accepted after the close.
What is Molbio Diagnostics IPO GMP today?
Molbio Diagnostics IPO GMP is ₹120 today (+14.87% over issue price ₹807). See live GMP on the Molbio Diagnostics IPO GMP Today page.
What is Molbio Diagnostics IPO issue price and lot size?
Molbio Diagnostics IPO issue price is ₹807 per share. Lot size is 18 shares. Minimum investment is ₹14,526 per lot. Issue size: ₹939.70 Cr.
When is Molbio Diagnostics IPO listing date?
Molbio Diagnostics IPO listing date is 17 August 2026 on NSE and BSE. Allotment is on 13 August 2026.
How does subscription affect Molbio Diagnostics IPO allotment?
In Molbio Diagnostics IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 70.26x overall, competition is very high.
For allotment results from 13 August 2026, visit the Molbio Diagnostics IPO Allotment Status page. For listing day updates on 17 August 2026, download the IPOwiz App.
Sources
We match Molbio Diagnostics IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- IPO RegistrarRegistrar details are on the allotment page for this IPO
Also read our Editorial Policy, How GMP is calculated, and How allotment chances work.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.